title: The effect of intralesional bleomycin on canine acanthomatous epulis.
abstract: Four dogs with recurrent acanthomatous epulis (AE) were injected with bleomycin (5 mg) intralesionally once a week. In three cases, tumors were clinically indistinguishable within three-to-eight weeks. In the fourth case, the tumor disappeared after 10 weekly injections. Through the administration period of bleomycin, no adverse reactions were recognized in any case. Electron microscopic examination together with a decrease in the percentage of mitotic cells implied that bleomycin might inhibit deoxyribonucleic acid (DNA) synthesis of tumor cells.
authors.affiliation: Department of Veterinary Pathology, Gifu University, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Yoshida
authors.forename: Y
authors.initials: Y
authors.lastname: Watarai
authors.forename: Y
authors.initials: Y
authors.lastname: Sakai
authors.forename: T
authors.initials: T
authors.lastname: Yanai
authors.forename: T
authors.initials: T
authors.lastname: Masegi
authors.forename: T
authors.initials: T
authors.lastname: Iwasaki
mesh_terms: D000564:Ameloblastoma / Q000188:drug therapy / Q000662:veterinary*; D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage*; D001761:Bleomycin / Q000008:administration & dosage*; D004273:DNA, Neoplasm / Q000096:biosynthesis / Q000187:drug effects; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D005260:Female; D005887:Gingival Neoplasms / Q000188:drug therapy / Q000662:veterinary*; D015552:Injections, Intralesional; D008297:Male; D009364:Neoplasm Recurrence, Local
chemical_list: D000964:Antimetabolites, Antineoplastic; D004273:DNA, Neoplasm; D001761:Bleomycin